EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

PEGASYSTEMS INC.    101 Main Street,                    
     Cambridge, MA. 02142-1590. USA.                    

 

[PEGASYSTEMS LOGO APPEARS HERE]

 

FOR IMMEDIATE RELEASE

 

For information, contact:

Chris Sullivan

Chief Financial Officer

Pegasystems Inc.

(617) 374-9600, ext. 6020

chris.sullivan@pega.com

 

Beth Lewis

Director, Investor Relations

Pegasystems Inc.

(617) 374-9600, ext. 6077

beth.lewis@pega.com

 

Pegasystems Reports Second Quarter Revenue of $24 Million,

Continued Success with PegaRULES Process Commander

 

New clients include chip manufacturer and medical equipment provider

 

CAMBRIDGE, Mass., July 28, 2004 Pegasystems today announced its 2004 second quarter results, reporting revenue of $24 million, pre-tax profits of $3.3 million, earnings per diluted share of $0.06 and positive cash flow from operations of $2.4 million.

 

Second Quarter Financial Performance

     Quarter

 
(In millions, except per share data and percentages)    Q2 2004

    Q1 2004

    Q2 2003

 

Total Revenue

   $ 24.0     $ 24.7     $ 25.5  

License Revenue

   $ 11.7     $ 9.7     $ 15.9  

% of Total Revenue

     49 %     39 %     63 %

Services Revenue

   $ 12.4     $ 15.0     $ 9.6  

% of Total Revenue

     51 %     61 %     37 %

Pre-tax Income

   $ 3.3     $ 2.7     $ 5.9  

Provision for income taxes

   $ 1.2     $ 0.9     $ 2.0  

Net Income

   $ 2.1     $ 1.7     $ 3.9  

Basic Earnings Per Share

   $ 0.06     $ 0.05     $ 0.11  

Diluted Earnings Per Share

   $ 0.06     $ 0.05     $ 0.11  

 

Henry Ancona, President and Chief Operating Officer commented, “While the second quarter 2004 total revenue is down 6 percent year-over-year, excluding the $3.5 million anticipated reduction in revenue associated with the restructured First Data Resource agreement, total revenue increased versus the same quarter last year. Service revenue grew 29% year-over-year


based on growth in both consulting and maintenance revenues. We continue to see acceptance of our comprehensive business process management (BPM) software, PegaRULES Process Commander, with penetration into new markets during the second quarter including sales to a major chip manufacturer and a medical equipment provider. Perpetual and subscription license revenue grew $1.5 million, or 33%, from the prior year. As anticipated, fewer scheduled term license renewals in the second quarter of 2004, in conjunction with a larger than usual extension in the second quarter of 2003, resulted in a year-over-year decrease in term license revenue from $11.3 million to $5.6 million.

 

“During the quarter, the majority of our license signings were for PegaRULES Process Commander. License signings included three new names and two existing customers who expanded their Pegasystems relationships to encompass new uses of our technology. New customers include a semiconductor manufacturer who will use PegaRULES Process Commander in support of a fully automated factory systems environment. PegaRULES Process Commander was also purchased by a medical equipment provider in support of product and service delivery to 400,000 patients. As noted previously, the time from license sale to revenue recognition for our PegaRULES Process Commander platform is proving to be shorter than the cycle that has been typical for our other applications.

 

Ancona continued, “During the quarter, the majority of the sales were partner-assisted, including deals with IBM, Accenture, Cognizant and Satyam. Importantly, as our partners continue to build their BPM practices, we have expanded our alliance initiatives and as of June 30, 2004 we have trained more PRPC designers and implementers than all of last year.”

 

Chris Sullivan, CFO, commented, “This was a quarter of solid performance as we continue to see acceptance of our market-leading technology. The software industry as a whole has seen lengthening negotiations and delays in customer signings and we are not immune to these trends. As a result, we now expect 2004 revenue to be in the range of $95 to $106 million, with pre-tax income from $12 to $18 million, and cash flow from operations in the range of $10 to $16 million.”

 

Page 2 of 7


Founder and CEO Alan Trefler commented, “Through the first half of the year we have now sold our sophisticated business process management system to users ranging from one of the largest defense contractors to a mid-sized medical equipment and services provider. Customers are buying our product for uses ranging from compliance to marketing to global tax analysis. Buyers increasingly understand the importance of managing complex, changing business processes through the power of rules and are increasingly looking at Pegasystems for our PegaRULES-based BPM capabilities.”

 

The Company will be hosting a conference call and live Webcast associated with this announcement at 9:00 a.m. ET on Thursday, July 29, 2004. Dial-in information is as follows: 800-250-4434 (domestic) or 706-634-0667 (international). A replay of the teleconference will be available through August 5 at 800-642-1687 (domestic) or 706-645-9291 (international), passcode 8765629.

 

If interested in listening to the Webcast, log onto www.pega.com at least 5 minutes prior to the event’s broadcast, and click on the Webcast icon in the Investor Relations section.

 

Page 3 of 7


About Pegasystems

Pegasystems Inc. (Nasdaq: PEGA) provides rules-based, smart business process management (BPM) software to large organizations, helping to deliver significant ROI and providing them with the flexibility and agility to respond to changing business needs. The company offers applications for the financial services, healthcare, insurance and government markets, as well as a cross-industry BPM application. Pegasystems is headquartered in Cambridge, Mass., and has regional offices in North America, Europe and the Pacific Rim. For more information, visit www.pega.com.

 

Forward-Looking Statements

Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 including without limitation our financial guidance with respect to 2004 revenue, pre-tax income and cash flow from operations. The words “believe,” “expect,” “hope,” “anticipate,” “plan” and similar expressions, among others, identify forward-looking statements, which speak only as of the date the statement was made. These statements are based on current expectations and assumptions and involve various risks and uncertainties, which could cause the Company’s actual results to differ from those expressed in such forward-looking statements. These risks and uncertainties include volatility of our quarterly operating results, difficulty in predicting the completion of product implementations and consequently the timing of our license revenue recognition, our ability to develop new products and evolve existing ones, the impact on our business of the ongoing consolidation in the financial services and healthcare markets, historically our core markets, our ability to attract and retain key employees, reliance on certain key third-party relationships, and other risks and uncertainties. Further information regarding these and other factors which could cause the Company’s actual results to differ materially from any forward-looking statements contained in this press release is contained in the Company’s most recent report on form 10-Q or 10-K and other recent filings on file with the Securities and Exchange Commission. The forward-looking statements contained in this press release represent the Company’s views as of July 28, 2004. Investors are cautioned not to place undue reliance on such forward-looking statements and there are no assurances that the matters contained in such statements will be achieved. Although subsequent events may cause the Company’s view to change, the Company does not undertake and specifically disclaims any obligation to publicly update or revise these forward-looking statements whether as the result of new information, future events or otherwise. The statements should therefore not be relied upon as representing the Company’s view as of any date subsequent to July 28, 2004.

 

###

 

Page 4 of 7


PEGASYSTEMS INC.

 

Condensed Consolidated Balance Sheets

(in thousands, except share-related amounts)

 

    

June 30,

2004


   

December 31,

2003


 
Assets                 

Current assets:

                

Cash and equivalents

   $ 49,957     $ 67,989  

Short-term investments

     45,263       19,946  
    


 


Total cash and short-term investments

     95,220       87,935  

Trade accounts receivable, net of allowance for doubtful accounts of $365 in 2004 and 2003

     9,937       9,602  

Short-term license installments

     33,128       28,565  

Prepaid expenses and other current assets

     1,221       727  
    


 


Total current assets

     139,506       126,829  

Long-term license installments, net of unearned interest income

     44,733       53,666  

Equipment, furniture and improvements, net of accumulated depreciation and amortization

     1,208       992  

Acquired technology, net of accumulated amortization

     554       729  

Other assets

     144       166  

Goodwill

     2,346       2,346  
    


 


Total assets

   $ 188,491     $ 184,728  
    


 


Liabilities and Stockholders’ Equity                 

Current liabilities:

                

Accrued payroll related expenses

   $ 5,285     $ 8,886  

Accounts payable and accrued expenses

     8,087       7,784  

Deferred revenue

     13,224       14,180  
    


 


Total current liabilities

     26,596       30,850  

Deferred income taxes

     1,875       625  

Other long-term liabilities

     81       81  
    


 


Total liabilities

     28,552       31,556  
    


 


Commitments and contingencies

                

Stockholders’ equity:

                

Preferred stock, $0.01 par value, 1,000,000 shares authorized; no shares issued and outstanding

     —         —    

Common stock, $0.01 par value, 70,000,000 shares authorized; 35,759,283 shares and 35,212,505 shares issued and outstanding in 2004 and 2003, respectively

     358       352  

Additional paid-in capital

     120,791       117,391  

Stock warrants

     211       374  

Retained earnings

     37,599       33,735  

Accumulated other comprehensive income (loss):

                

Net unrealized loss on short-term investments

     (183 )     (9 )

Foreign currency translation adjustments

     1,163       1,329  
    


 


Total stockholders’ equity

     159,939       153,172  
    


 


Total liabilities and stockholders’ equity

   $ 188,491     $ 184,728  
    


 


 

Page 5 of 7


PEGASYSTEMS INC.

 

Condensed Consolidated Statements of Income

(in thousands, except per share amounts)

 

    

Three Months Ended

June 30,


  

Six Months Ended

June 30,


     2004

    2003

   2004

    2003

Revenue:

                             

Software license

   $ 11,677     $ 15,937    $ 21,340     $ 32,134

Services

     12,363       9,550      27,357       18,977
    


 

  


 

Total revenue

     24,040       25,487      48,697       51,111
    


 

  


 

Cost of revenue:

                             

Cost of software license

     87       88      175       175

Cost of services

     6,028       6,525      12,680       12,921
    


 

  


 

Total cost of revenue

     6,115       6,613      12,855       13,096
    


 

  


 

Gross profit

     17,925       18,874      35,842       38,015
    


 

  


 

Operating expenses:

                             

Research and development

     4,826       5,438      10,311       10,198

Selling and marketing

     7,838       6,379      15,656       11,912

General and administrative

     2,754       2,879      5,689       5,389
    


 

  


 

Total operating expenses

     15,418       14,696      31,656       27,499
    


 

  


 

Income from operations

     2,507       4,178      4,186       10,516
    


 

  


 

Installment receivable interest income

     680       1,350      1,387       2,550

Other interest income, net

     466       130      769       335

Other (expense) income, net

     (371 )     260      (378 )     221
    


 

  


 

Income before provision for income taxes

     3,282       5,918      5,964       13,622

Provision for income taxes

     1,160       2,000      2,100       2,900
    


 

  


 

Net income

   $ 2,122     $ 3,918    $ 3,864     $ 10,722
    


 

  


 

Earnings per share:

                             

Basic

   $ 0.06     $ 0.11    $ 0.11     $ 0.31
    


 

  


 

Diluted

   $ 0.06     $ 0.11    $ 0.10     $ 0.30
    


 

  


 

Weighted average number of common and common equivalent shares outstanding:

                             

Basic

     35,648       34,337      35,521       34,345
    


 

  


 

Diluted

     37,055       35,516      37,095       35,261
    


 

  


 

 

Page 6 of 7


PEGASYSTEMS INC.

 

Condensed Consolidated Statements of Cash Flows

(in thousands)

 

    

Six Months Ended

June 30,


 
     2004

    2003

 

Cash flows from operating activities:

                

Net income

   $ 3,864     $ 10,722  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Stock option income tax benefits

     634       252  

Deferred income taxes

     1,250       1,100  

Depreciation and amortization

     687       860  

Reduction in provision for doubtful accounts receivable

     —         (90 )

Changes in operating assets and liabilities:

                

Trade accounts receivable and license installments

     3,915       (9,222 )

Prepaid expenses and other current assets

     (396 )     258  

Accounts payable and accrued expenses

     (3,258 )     1,537  

Deferred revenue

     (956 )     5,222  
    


 


Net cash provided by operating activities

     5,740       10,639  
    


 


Cash flows from investing activities:

                

Purchase of investments

     (36,698 )     (3,620 )

Maturing and called investments

     9,350       4,799  

Sale of investments

     1,749       —    

Purchase of equipment, furniture and improvements

     (617 )     (84 )

Other long-term assets and liabilities

     17       (20 )
    


 


Net cash (used in) provided by investing activities

     (26,199 )     1,075  
    


 


Cash flows from financing activities:

                

Proceeds from sale of stock under Employee Stock Purchase Plan

     329       253  

Exercise of stock options

     2,280       419  
    


 


Net cash provided by financing activities

     2,609       672  
    


 


Effect of exchange rate on cash and equivalents

     (182 )     346  
    


 


NET (DECREASE) INCREASE IN CASH AND EQUIVALENTS

     (18,032 )     12,732  
    


 


CASH AND EQUIVALENTS, BEGINNING OF PERIOD

     67,989       57,393  
    


 


CASH AND EQUIVALENTS, END OF PERIOD

   $ 49,957     $ 70,125  
    


 


 

Page 7 of 7